Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Neda Kazeminia"'
Autor:
Mohammad Mahdi Rabiei, Sajad Shojaee, Farid Javandoust Gharehbagh, Firouze Hatami, Hadi Allahverdi Nazhand, Hadi Ebadi, Amir Hossein Zeininasab, Shahrzad Shahrokhi, Neda Kazeminia, Legha Lotfollahi, Ilad Alavi Darazam
Background: There are increasing reports regarding macrolide resistance in Mycoplasma pneumoniae, particularly in Asia. Indiscriminate consumption of macrolide could be an alarming sign worldwide. We aimed to systematically review and analyze the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::450532785623a0f4acd8509d9fc6a9eb
https://doi.org/10.21203/rs.3.rs-2032623/v1
https://doi.org/10.21203/rs.3.rs-2032623/v1
Autor:
Firouze Hatami, Hadi Allahverdi Nazhand, Hadi Ebadi, Amir Hossein Zeininasab, Farid Javandoust Gharehbagh, Shahrzad Shahrokhi, Mohammad Mahdi Rabiei, Legha Lotfollahi, Neda Kazeminia, Ilad Alavi Darazam
Introduction: Haemophilus. influenzae and Moraxella. catarrhalis are two common pathogens in respiratory tract infections. Antimicrobial resistance to these pathogens occurs over years. Therefore, we decided to carry out a systematic review to invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7398a5b3cd419086d1ad86af5dffdd6
https://doi.org/10.21203/rs.3.rs-1989291/v1
https://doi.org/10.21203/rs.3.rs-1989291/v1
Autor:
Neda, Kazeminia, Mahshid, Mehdizadeh, Jamshid, Salamzadeh, Sayeh, Parkhideh, Farzaneh, Dastan, Arash, Mahboubi, Maria, Tavakoli-Ardakani
Publikováno v:
Iranian journal of pharmaceutical research : IJPR. 20(4)
Mobilization and engraftment of Hematopoietic Stem Cells (HSCs) are challenging issues in Autologous HSC transplantation (AHSCT) so several attempts such as colony-stimulating factors (CSF) and plerixafor have been used for enhancement of HSCs mobili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d245ff6585b93bde835ffc9895909294
https://pubmed.ncbi.nlm.nih.gov/35194433
https://pubmed.ncbi.nlm.nih.gov/35194433
Publikováno v:
International Immunopharmacology
Since late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, better known as COVID-19) has rapidly spread worldwide. The primary pathophysiology by which COVID-19 leads to severe lung damage is cytokine releasing syndrome (CRS), whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6a447c5741b703b2ccbbd5acb23013
https://doi.org/10.1016/j.intimp.2021.107707
https://doi.org/10.1016/j.intimp.2021.107707